Literature DB >> 21971187

Staphylococcus aureus survival in human blood.

Natalia Malachowa1, Frank R DeLeo.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is abundant in hospitals and in the United States is a leading cause of mortality due to infectious agents. Community-associated MRSA (CA-MRSA) strains such as USA300, which typically cause disease outside of healthcare settings, are also prevalent in the United States. Although most CA-MRSA infections affect skin and soft tissue, the pathogen can enter the bloodstream and ultimately cause severe disease. In a recent paper, we used USA300-specific microarrays to generate a comprehensive view of the molecules that facilitate S. aureus immune evasion and survival in human blood. Notably, genes encoding proteins involved in iron-uptake and utilization and gamma-hemolysin (hlgABC) are highly up-regulated by USA300 during culture in human blood. Here we discuss the potential implication of these findings and the possible role of gamma-hemolysin in the success of S. aureus as a human pathogen.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971187      PMCID: PMC3260549          DOI: 10.4161/viru.2.6.17732

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  1 in total

1.  Global changes in Staphylococcus aureus gene expression in human blood.

Authors:  Natalia Malachowa; Adeline R Whitney; Scott D Kobayashi; Daniel E Sturdevant; Adam D Kennedy; Kevin R Braughton; Duncan W Shabb; Binh An Diep; Henry F Chambers; Michael Otto; Frank R DeLeo
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

  1 in total
  15 in total

Review 1.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

2.  Genomic Heterogeneity of Methicillin Resistant Staphylococcus aureus Associated with Variation in Severity of Illness among Children with Acute Hematogenous Osteomyelitis.

Authors:  Claudia Gaviria-Agudelo; Chukwuemika Aroh; Naureen Tareen; Edward K Wakeland; MinSoo Kim; Lawson A Copley
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

3.  Identification of staphylococcal phage with reduced transcription in human blood through transcriptome sequencing.

Authors:  Tasha M Santiago-Rodriguez; Mayuri Naidu; Marcus B Jones; Melissa Ly; David T Pride
Journal:  Front Microbiol       Date:  2015-03-24       Impact factor: 5.640

4.  Phenotypic Variation Is Almost Entirely Independent of the Host-Pathogen Relationship in Clinical Isolates of S. aureus.

Authors:  Adrian D Land; Patrick Hogan; Stephanie Fritz; Petra Anne Levin
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

5.  Regulation of Staphylococcus aureus MntC expression and its role in response to oxidative stress.

Authors:  Luke D Handke; Julio C Hawkins; Alita A Miller; Kathrin U Jansen; Annaliesa S Anderson
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

6.  Serine-Aspartate Repeat Protein D Increases Staphylococcus aureus Virulence and Survival in Blood.

Authors:  Fatemeh Askarian; Satoshi Uchiyama; J Andrés Valderrama; Clement Ajayi; Johanna U E Sollid; Nina M van Sorge; Victor Nizet; Jos A G van Strijp; Mona Johannessen
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

7.  Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.

Authors:  Hatice Karauzum; Rajan P Adhikari; Jawad Sarwar; V Sathya Devi; Laura Abaandou; Christian Haudenschild; Mahta Mahmoudieh; Atefeh R Boroun; Hong Vu; Tam Nguyen; Kelly L Warfield; Sergey Shulenin; M Javad Aman
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

8.  Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.

Authors:  Rajan P Adhikari; Thomas Kort; Sergey Shulenin; Tulasikumari Kanipakala; Nader Ganjbaksh; Mary-Claire Roghmann; Frederick W Holtsberg; M Javad Aman
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 9.  Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy.

Authors:  M Javad Aman; Rajan P Adhikari
Journal:  Toxins (Basel)       Date:  2014-03-04       Impact factor: 4.546

10.  Comparative Genomics Analysis of Streptococcus tigurinus Strains Identifies Genetic Elements Specifically and Uniquely Present in Highly Virulent Strains.

Authors:  Seydina M Diene; Patrice François; Andrea Zbinden; José Manuel Entenza; Grégory Resch
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.